Although best known for its food and beverage operations, Nestlé also has a Health Science business that generates approximately USD 3 billion annually for the Swiss conglomerate. Hanzade Yaz, General Manager of Nestlé Health Science Turkey, discusses the affiliate’s leading position in medical nutrition, portfolio expansion following recent global acquisitions – including the first and only FDA and EMA-approved treatment for peanut allergy – and their upcoming manufacturing site which will be the first for enteral nutrition in Turkey. In addition, Hanzade explains what Nestlé’s “Creating Shared Value” approach means in Turkey and emphasizes their sustainability goals.
Turkey is an attractive investment destination due to its dynamic economy, young population and comprehensive national health system which covers most people living in Turkey, not to mention the strong healthcare infrastructure currently in place
